The FDA is
killing 700 Americans per day (
average first 4 days of October)
that could theoretically otherwise be reduced to just 7 (1%) even within a few weeks, through treatment of COVID-19 patients with
hydroxychloroquine+zinc+Azithromycin when administered in the
early outpatient setting immediately upon the presentation of symptoms or clinical suspicion of COVID-19, including in elderly or other high-risk individuals. We know this because skilled clinicians like Dr. Vladimir Zelenko enjoyed a 99.9% success rate over 2,200 patients in Monroe New York, Dr. Didier Raoult in France had 99.5% success in a peer reviewed study of 1,061 patients and Dr. Stella Emmanuel in Texas enjoyed a 100% success rate in well over 350 COVID patients through the use of HCQ+Z+AZ.
https://www.covid-19forum.org/index.php?topic=18.0Billions or even trillions of Big Pharma potential profits - and potentially massive profits from a dangerously rushed
Bill Gates/WHO vaccine - are threatened, by the safe, up to 100% effective, $14-20 Zelenko Protocol utilizing an off-patent 65-year old drug in conjunction with another off-patent 40-year old drug plus a zinc supplement.
So it would seem the lives of American citizens are of no value, in comparison to the opportunity for the pharmaceutical and hospital illness industries to fleece the American people, through greedily priced, less effective medications and a rushed vaccine.
https://www.covid-19forum.org/index.php?topic=296.0So the FDA removed Emergency Use Authorization for hydroxychloroquine which enjoys a 65-year track record of safety (according to the AAPS safer than aspirin, Tylenol or Benadryl and is sold over-the-counter in many countries) - that effectively put HCQ outside of the "standard of care" (which makes profit-driven
CYA doctors too paranoid to prescribe it) - to instead give EUA to Gilead sciences patented $3,200 per course of treatment Remdesivir, which is an experimental drug that
so far is known to damage the kidneys and liver, the efficacy of which the NIH's own study concluded the "difference in mortality was not statistically significant".
https://www.covid-19forum.org/index.php?board=7.0So on one hand we have a
safe up to 100% effective drug in the early outpatient setting, that physicians have been scared out of using by the FDA's citing fraudulent designed-to-fail studies as a bankrupt reason to demonize HCQ and remove its EUA, while on the other hand we have
FDA granting EUA to an experimental new drug (that failed as an Ebola drug)
with known serious short term side effects while the long term side effects are still unknown, that does not produce a statistically significant reduction in mortality, that can only be administered by IV in the
hospital INpatient setting. So Gilead doesn't stand to make the $3,200 (or $6,400 for 10-day course of treatment) per patient on its (
$9.32 cost to manufacture) IV drug,
unless a patient is encouraged to degenerate beyond the outpatient setting and then require hospitalization. So the purpose behind Fauci's bizarre
"go home and isolate" remedy for COVID would seem to come sharply into focus along with the demonizing of the successful $14 HCQ+Z+AZ protocol, which has resulted in the
completely unnecessary deaths of at least 150,000 Americans - so far.
So if 99% of COVID patients were being cured in the outpatient setting, we wouldn't need a vaccine, or expensive new therapeutic drugs, or any new remedies whatsoever. Would we even need masking or social distancing as we reached herd immunity within months?
As the world renowned microbiologist, virologist and epidemiologist Dr. Didier Raoult noted, COVID-19 is the easiest to cure virus that has come along - when treated early.
Need we do more than consider the 75% lower death rate among countries that have widespread early use of HCQ compared to countries like the U.S. and Mexico that have limited or late use of HCQ?
https://www.covid-19forum.org/index.php?topic=243.0"Many countries either adopted or declined early treatment with HCQ,
effectively forming a large trial with 1.8 billion people in the treatment group and 663 million in the control group. As of September 15, 2020, an average of 65.1 per million in the treatment group have died, and 471.8 per million in the control group, relative risk 0.138. After adjustments, treatment and control deaths become 136.2 per million and 704.7 per million, relative risk 0.19. The probability of an equal or lower relative risk occurring from random group assignments is 0.013. Accounting for predicted changes in spread, we estimate a relative risk of 0.25.
The treatment group has a 74.8% lower death rate. Confounding factors affect this estimate. We examined diabetes, obesity, hypertension, life expectancy, population density, urbanization, testing level, and intervention level, which do not account for the effect observed."
https://hcqtrial.com/
Why do poor African countries enjoy less than 1% of the COVID death rate that "developed" western countries have?https://www.bitchute.com/video/xR4druFBssHd/
